The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

NCT04286841 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Immunotherapy
Lung Cancer

Interventions

DRUG: Immunotherapy

Sponsor

Guangdong Association of Clinical Trials